期刊文献+

CD8+CTL在乙型肝炎发病作用中的研究现状及进展 被引量:9

Current status and advance of CD8+CTL in occurrence of hepatitis B
下载PDF
导出
摘要 乙型肝炎的发病机制主要是机体清除乙肝病毒(hepatitis B virus,HBV)而引发的细胞免疫损伤.机体产生的针对HBV的细胞毒性T细胞(cytotoxic T cell,CTL)在病毒清除及肝细胞损伤方面均起关键作用.CD8+CTL是CTL的主要功能亚群,他们通过细胞毒机制和非细胞毒机制清除病毒.在急性自限性HBV感染时,CTL应答呈多克隆性和多特异性,能够及时清除病毒;而在慢性HBV感染时,CTL应答呈单克隆性和寡特异性,导致HBV持续感染.慢性HBV感染可能与CD8+CTL数量不足及功能缺陷有关. The cellular immune response is thought to play a critical role in viral clearance and disease pathogenesis during HBV infection. Cytotoxic T-lymphocytes (CTLs) response to HBV plays a key role in the viral clearance and liver cell injuries. As a main subpopulation of CTL, CD8+CTL can eliminate viral through cytotoxic mechanism and non-cytotoxic mechanism. In acute hepatitis B, the CTL response is polyclonal and multispecific, which can eliminate the virus in time; but the CTL response is monoclonal and monospecific in chronic HBV infection, which causes persistent HBV infection. This may be concerned with the dysfunction and insufficiency of the CD8+CTL.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第4期384-388,共5页 World Chinese Journal of Digestology
关键词 乙型肝炎病毒 CD8+CTL 功能缺陷 Hepatitis B virus CD8+CTL Dysfunction
  • 相关文献

参考文献24

  • 1Keefe D, Shi L, Feske S, Massol R, Navarro F, Kirchhausen T, Lieberman J. Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis. Immunity 2005; 23: 249-262
  • 2Wieland SF, Spangenberg HC, Thimme R, Purcell RH, Chisari FV. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci U S A 2004; 101: 2129-2134
  • 3Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Viro12003; 77:68-76
  • 4Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284:825-829
  • 5Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis 2002; 2:43-50
  • 6Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, King AS, Herberg J, Gilson R, Alisa A, Williams R, Vergani D, Naoumov NV, Ferrari C, Bertoletti A. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000; 191: 1269-1280
  • 7Sobao Y, Tomiyama H, Sugi K, Tokunaga M,Ueno T, Saito S, Fujiyama S, Morimoto M, Tanaka K, Takiguchi M. The role of hepatitis B virusspecific memory CD8 T cells in the control of viral replication. J Hepato12002; 36:105-115
  • 8Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C, Cavalli A, Urbani S, Boehme R, Panebianco R, Fiaccadori F, Ferrari C. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33:963-971
  • 9Tsai SL, Lee TH, Chien RN, Liao SK, Lin CL, Kuo GC, Liaw YF. A method to increase tetramer staining efficiency of CD8+ T cells with MHC- peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment. J Immunol Methods 2004; 285:71-87
  • 10张蓓,付晓岚,王靖雪,韩俊峰,吴玉章.乙型肝炎患者HBcAg18-27表位特异性细胞毒性T细胞的研究[J].免疫学杂志,2007,23(3):319-322. 被引量:19

二级参考文献14

  • 1Penna A, Chisari FV,Bertoletti A,et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen [ J]. J Exp Med,1991, 174 (6): 1 565- 1 570.
  • 2EASL Jury, EASL International Consensus Conference on Hepatitis B, 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version) [J]. J Hepatol, 2003, 38 (4) : 533 - 540.
  • 3Cacciola I, Pollicino T, Squadrito G, et al. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection [ J ]. Hepatology, 2000, 31 (2) : 507-512.
  • 4Lok AS, McMahon BJ. Chronic hepatitis B [J]. Hepatology, 2001, 34 (6): 1 225- 1 241.
  • 5Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis [J]. Annu Rev Immunol, 1995, 13: 29-60.
  • 6Rehennann B, Chisari FV. Cell mediated immune response to the hepatitis C virus [ J]. Curr Top Microbiol Immunol, 2000, 242: 299-.325.
  • 7Rehermann B, Fowler P, Sidney J, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis [ J]. J Exp Med, 1995, 181 (3) : 1 047- 1 058.
  • 8Altman JD, Moss PA, Goulder PJ, et al. Phenotypic analysis of antigen-specific T lymphocytes [ J ]. Science, 1996, 274(5284) : 94 - 96.
  • 9Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8^+ cells in liver damage and viral control during persistent hepatitis S virus infection [J]. J Exp Med, 2000, 191 (S) : 1269-1280.
  • 10Kakimi K, Isogawa M, Chang J, et al. Immunogenicity and tolemgenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections [J]. J Viral, 2002, 76 (17): 8609-8620.

共引文献18

同被引文献83

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部